Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  McCarthy, Suzanne ^a,b   Wilton, Lynda ^c   Murray, Macey L ^c   Hodgkins, Paul ^d   Asherson, Philip ^e   Wong, Ian C K ^c,f  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d SHIRE   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adulthood; Attention deficit hyperactivity disorder; Persistence; Pharmacological treatment; Stimulants

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; DATA ANALYSIS; DATA BASE; DATA EXTRACTION; DESCRIPTIVE RESEARCH; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHARMACEUTICAL CARE; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; SCHOOL CHILD; TREATMENT DURATION; UNITED KINGDOM; ADOLESCENT DISEASE; ADULT; CHILDHOOD DISEASE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; FEMALE; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METHYLPHENIDATE; PATIENT COMPLIANCE; PROPYLAMINES;

EID: 84870326697     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-219     Document Type: Article

References (40)

1. Attention deficit hyperactivity disorder pharmacological and psychological interventions in children, young people and adults http://www.nice.org.uk/CG72, Attention deficit hyperactivity disorder.
2. Rosler M, Casas M, Konofal E, Buitelaar J. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry 2010, 11(5):684-698.
3. Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010, 10:67.
4. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 2005, 5(4):525-539.
5. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409.
6. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009, 194(3):204-211.
7. Methylphenidate atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents Technology Appraisal 98 http://www.nice.org.uk/TA98, Methylphenidate.
8. World Health Organisation International classification of diseases, 10th revision: the classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992, Geneva: WHO, World Health Organisation.
9. Mental health of children and young people in Great Britain 2004, http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4118332.
10. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48(1):9-20.
11. Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. JAMA 2004, 292(5):619-623.
12. Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry 2011, 53(3):304-312.
13. Young SJ, Adamou M, Bolea B, Gudjonsson G, Muller U, Pitts M, Thome J, Asherson P. The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry 2011, 11:32.
14. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36(2):159-165.
15. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000, 157(5):816-818.
16. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Development http://www.dsm5.org.
17. Janssen-Cilag L. Concerta XL. Summary of Product Characteristics. Electronic Medicines Compendium Available from URL:http://www.medicines.org.uk/EMC/medicine/19549/SPC/Concerta; [updated 13/09/2011] Accessed: 15th November 2011.
18. Eli Lilly and Company Limited Atomoxetine (Strattera) Summary of Product Characteristics. Electronic Medicines Compendium Available fromhttp://www.medicines.org.uk/EMC/medicine/14482/SPC/Strattera; [updated 08/12/2011] Accessed: 15th June 2011, Eli Lilly and Company Limited.
19. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA) Canadian ADHD Practice Guidelines 2011, Toronto ON, Third, Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA).
20. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2007, 21(1):10-41.
21. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009, 194(3):273-277.
22. The MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999, 56(12):1073-1086. The MTA Cooperative Group.
23. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004, 113(4):754-761. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up.
24. Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 2007, 46(8):989-1002.
25. McBride D, Hardoon S, Walters K, Gilmour S, Raine R. Explaining variation in referral from primary to secondary care: cohort study. BMJ 2010, 341:c6267.
26. Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf 2009, 18(8):730-736.
27. Lo Re V, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf 2009, 18(9):807-814.
28. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16(4):393-401.
29. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong ICK. The epidemiology of pharmacologically-treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatrics 2012, 12:78.
30. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163(4):716-723.
31. Miller VA, Drotar D. Decision-making competence and adherence to treatment in adolescents with diabetes. J Pediatr Psychol 2007, 32(2):178-188.
32. National Service Framework for Children Young People and Maternity Services. Transition: Getting it Right for Young People UK: Improving the Transition of Young People with Long-Term Conditions from Children's to Adult Health Services, http://www.dh.gov.uk/assetRoot/04/13/21/49/04132149.pdf, National Service Framework for Children.
33. Asherson P, Chen W, Craddock B, Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 2007, 190:4-5.
34. ADHD - Services Over Scotland. Report of the Service Profiling Exercise http://www.healthcareimprovementscotland.org/programmes/mental_health/adhd/adhd_service_profile.aspx.
35. Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess 2009, 13(50):1-120. iii-iv, ix-xi.
36. Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 2005, 35(6):817-827.
37. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012, 10(1):99.
38. Morgan O, Griffiths C, Majeed A. Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004. J Public Health (Oxf) 2008, 30(1):60-68.
39. Martin-Merino E, Ruigomez A, Wallander MA, Johansson S, Garcia-Rodriguez LA. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam Pract 2010, 27(1):9-16.
40. Kessler R, Adler L, Barkley R, Biederman J, Conners CK, Faraone S, Greenhill L, Jaeger S, Secnik K, Spencer T, et al. Patterns and predictors of ADHD persistence into adulthood: Results from the National Comorbidity Survey Replication. Biol Psychiatry 2005, 57(11):1442-1451.